Anthony Gregg Lapointe is Director at RIGEL PHARMACEUTICALS INC (RIGL). They have made 1 open-market trade across 1 company since 2010, most recently 2026-05-15.
CIK 0001331860
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $205K since 2010, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SNGX | BUY | 2010-06-18 | 2010-06-22 | $0.21 | $205K | -12.8% | -21.0% | -21.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.